Executive Summary and Global Market Analysis
The global cancer therapeutics market is experiencing significant momentum, propelled by the escalating burden of breast and lung cancer and increased investment in oncology research. Cancer therapeutics encompass a diverse range of treatments aimed at managing or curing cancer. Primary treatment modalities frequently employed include chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgical interventions, and stem cell therapy. All these strategies aim to eliminate or control cancer cells, mitigate symptoms, and improve patient survival. Treatment often involves combining multiple therapies, tailored to the specific type and stage of cancer, as well as the patient's general health, to maximize efficacy.
Download our Sample PDF Report
@ https://www.businessmarketinsights.com/sample/BMIRE00031299
Cancer Therapeutics Market Segmentation Analysis
The cancer therapeutics market is segmented for analysis based on therapy type, indication, and distribution channel.
By therapy type, the cancer therapeutics market is divided into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other forms of therapy. Chemotherapy held the largest share of the market in 2024.
Regarding indications, the market is segmented into blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. Lung cancer accounted for the largest share of the market in 2024.
By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the largest share of the market in 2024.
Cancer Therapeutics Market Drivers and Opportunities
As per the World Health Organization, various types of cancer are responsible for approximately 1 in every 6 deaths globally. In 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths associated with the disease; this burden is projected to increase by roughly 77% by 2050, which will further strain health systems and communities. The American Cancer Society reports that 5–10% of all cancers are inherited from parents. Numerous genes associated with cancer predisposition have been identified. For example, mutations in inherited cancer predisposition genes like BRCA1 and BRCA2 increase the risk of developing various cancers, including breast, ovarian, and prostate cancer. Breast cancer is considered the most prevalent cancer among women worldwide, with a continuously rising incidence attributed to risk factors such as environmental impact, genetic susceptibility, hormone imbalances, and lifestyle changes. Additionally, breast cancer is among the most prevalent cancers in the U.S.
Cancer Therapeutics Market Size and Share Analysis
By therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment dominated the market in 2024. Chemotherapy can stop or slow down the growth of cells through the cytotoxic ability of drugs. These drugs circulate in the bloodstream throughout the body and operate by disrupting the growth of cancer cells. As per the National Institutes of Health estimates, ~650,000 cancer patients in the US receive chemotherapy each year in oncology clinics.
In terms of indications, the market is segmented into blood cancer, lung cancer, breast cancer, colorectum cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment held the largest share of the market in 2024.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
